Elevance Health, Inc. 2024 Annual Report (10-K) Summary
Business Context and Reporting Period
This summary covers the Annual Report on Form 10-K for Elevance Health, Inc. for the fiscal year ended December 31, 2024. Elevance is one of the largest health insurers in the United States, serving approximately 45.7 million medical members as of year-end. The company operates through four reportable segments: Health Benefits, CarelonRx (pharmacy services), Carelon Services (healthcare services), and Corporate & Other. It is an independent licensee of the Blue Cross and Blue Shield Association (BCBSA) and operates under brands including Anthem Blue Cross, Wellpoint, and Carelon.
Key Financial Metrics
| Metric | 2024 | 2023 | Change |
|---|---|---|---|
| Total Operating Revenue | $175.2 billion | $170.2 billion | +2.9% |
| Net Income | $5.97 billion | $5.99 billion | -0.3% |
| Diluted EPS | $25.68 | $25.22 | +1.8% |
| Operating Cash Flow | $5.81 billion | $8.06 billion | -28.0% |
| Total Assets | $116.9 billion | $108.9 billion | +7.3% |
| Total Debt | $30.9 billion | $24.9 billion | +24.1% |
| Debt-to-Capital Ratio | 43.0% | 38.9% | +410 bps |
| Benefit Expense Ratio | 88.5% | 87.0% | +150 bps |
Material Changes vs. Prior Period
- Membership Decline: Total medical membership decreased by 1.1 million (2.3%) to 45.7 million. This was primarily driven by a 15.1% decline in Medicaid membership due to eligibility redeterminations following the end of the COVID-19 public health emergency. Decreases in Employer Group risk-based and Medicare Supplement businesses also contributed.
- Revenue Growth: Operating revenue increased 2.9% despite membership declines, driven by premium rate increases across all lines of business, growth in CarelonRx product revenue, and recent acquisitions.
- Profitability Pressure: Net income remained flat while operating gain in the Health Benefits segment declined 9.4%. The benefit expense ratio increased to 88.5% as Medicaid rates proved inadequate to cover medical cost trends exceeding historical averages.
- Acquisitions and Divestitures: The company completed acquisitions of Paragon Healthcare (infusion services), CareBridge (virtual care), and Centers Plan for Healthy Living (long-term care). It also divested its life and disability businesses, recognizing a $201 million gain.
- Litigation Accruals: The company accrued an estimated $666 million for the Provider Settlement Agreement related to the Blue Cross Blue Shield Antitrust Litigation, recognized in the Corporate & Other segment.
Guidance, Outlook, and Risks
- Star Ratings Impact: CMS released 2025 Star Ratings in October 2024, showing a decrease in the percentage of members in plans rated 4.0 stars or higher (from 53% to 38%). Management expects this to reduce 2026 operating revenue by approximately $183 million, net of offsets.
- Regulatory Environment: The company faces ongoing uncertainty regarding the expiration of enhanced Premium Tax Credits (PTC) at the end of 2025, which could materially impact Individual Public Exchange enrollment. Continued Medicaid redeterminations are expected to persist through 2025.
- Capital Allocation: The company repurchased $2.9 billion of common stock in 2024. As of December 31, 2024, $9.3 billion remained authorized for repurchases. A quarterly dividend of $1.71 per share was declared in January 2025.
- Key Risks: Significant risks include the inability to predict healthcare costs accurately, cyber-attacks, changes in government regulations (ACA, Inflation Reduction Act), and the potential termination of BCBSA licenses, which could result in a $3 billion re-establishment fee.
Investor Verification Checklist
- Medicaid Cost Trends: Verify the sustainability of Medicaid margins given the reported inadequacy of rates to cover cost trends and the ongoing impact of eligibility redeterminations.
- Star Rating Trajectory: Monitor the company's ability to improve 2026 Star Ratings to mitigate the projected $183 million revenue reduction.
- Antitrust Litigation: Confirm the final approval and payment terms of the $666 million Provider Settlement Agreement and assess potential follow-on litigation risks.
- Debt Servicing: Review the impact of increased interest rates on the company's $30.9 billion debt load and future borrowing costs.
- Acquisition Integration: Assess the financial contribution and integration progress of 2024 acquisitions (Paragon, CareBridge, Centers) to offset membership attrition.